The Role of Complement Activation in Hypersensitivity to Pegylated Liposomal Doxorubicin (Doxil®) (original) (raw)

Journal of Liposome Research, 2000

Rolf Bunger

J. Szebeni

J. Szebeni

L. Baranyi

C. Alving

Abstract

Page 1. JOURNAL OF LIPOSOME RESEARCH, 10(4), 467-481 (2000) THE ROLE OF COMPLEMENT ACTIVATION IN HYPERSENSITIVITY TO PEGYLATED LIPOSOMAL DOXORUBICIN (DOXIL@) Janos Szebeni,B* Lajos ...

Rolf Bunger hasn't uploaded this paper.

Let Rolf know you want this paper to be uploaded.

Ask for this paper to be uploaded.